Showing results (1-10 of 8,127) with videos related to
Sort By:
Pageof 813
Current Topics in Medicinal Chemistry|August 26, 2015
Designing Prodrugs Based on Special Residues of Human Serum AlbuminYi Gou, Feng Yang, Hong LiangInternational Journal of Molecular Sciences|March 4, 2014
Interactive association of drugs binding to human serum albuminFeng Yang, Yao Zhang, Hong LiangCurrent Pharmaceutical Design|March 4, 2015
Evaluation of interactions between platinum-/ruthenium-based anticancer agents and human serum albumin: development of HSA carrier for metal-based drugsYi Gou, Yao Zhang, Feng Yang, et al.Primary Care Diabetes|March 5, 2021
The significant interaction between age and diabetes mellitus for colorectal cancer: Evidence from NHANES data 1999-2016Feng Yang, Hong Liang, Raul J Rosenthal, et al.Spectrochimica Acta. Part A, Molecular and Biomolecular Spectroscopy|April 5, 2014
DNA binding, cytotoxicity and apoptosis induction activity of a mixed-ligand copper(II) complex with taurine Schiff base and imidazoleMei Li, Lin Lin Kong, Yi Gou, et al.Journal of Inorganic Biochemistry|May 7, 2018
Structure and biological properties of five Pt(II) complexes as potential anticancer agentsJungang Deng, Jun Wang, MuhammadHamid Khan, et al.Journal of Inorganic Biochemistry|January 10, 2015
Enhancing the copper(II) complexes cytotoxicity to cancer cells through bound to human serum albuminYi Gou, Yao Zhang, Jinxu Qi, et al.Molecules (Basel, Switzerland)|July 25, 2019
Anticancer Function and ROS-Mediated Multi-Targeting Anticancer Mechanisms of Copper (II) 2-hydroxy-1-naphthaldehyde ComplexesMuhammad Hamid Khan, Meiling Cai, Jungang Deng, et al.Molecules (Basel, Switzerland)|October 13, 2021
Correction: Khan et al. Anticancer Function and ROS-Mediated Multi-Targeting Anticancer Mechanisms of Copper (II) 2-hydroxy-1-naphthaldehyde Complexes. Molecules 2019, 24, 2544Muhammad Hamid Khan, Meiling Cai, Jungang Deng, et al.Dalton Transactions (Cambridge, England : 2003)|December 15, 2022
Designing a multitarget In(III) compound to overcome the resistance of lung cancer cells to cisplatinMing Jiang, Juzheng Zhang, Shihang Xu, et al.Pageof 813